Cited by

• Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report.

  Nebesio TD, Eugster EA. Nebesio TD, et al. Endocrine. 2006 Dec;30(3):279-82. doi: 10.1007/s12020-006-0005-4. Endocrine. 2006. PMID: 17526939
• A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency.

  Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC. Speiser PW, et al. Int J Pediatr Endocrinol. 2010;2010:494173. doi: 10.1155/2010/494173. Epub 2010 Jun 30. Int J Pediatr Endocrinol. 2010. PMID: 20981249 Free PMC article.
• Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

  Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC; Endocrine Society. Speiser PW, et al. J Clin Endocrinol Metab. 2010 Sep;95(9):4133-60. doi: 10.1210/jc.2009-2631. J Clin Endocrinol Metab. 2010. PMID: 20823466 Free PMC article.
• The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

  Huynh T, McGown I, Cowley D, Nyunt O, Leong GM, Harris M, Cotterill AM. Huynh T, et al. Clin Biochem Rev. 2009 May;30(2):75-86. Clin Biochem Rev. 2009. PMID: 19565027 Free PMC article.
• Prenatal treatment of congenital adrenal hyperplasia-not standard of care.

  Witchel SF, Miller WL. Witchel SF, et al. J Genet Couns. 2012 Oct;21(5):615-24. doi: 10.1007/s10897-012-9508-8. Epub 2012 May 26. J Genet Couns. 2012. PMID: 22639328 Review.